Shares to Trade on the New York Stock Exchange Under Ticker Symbol "CRM"
SAN FRANCISCO, Calif. - June 23, 2004 - Salesforce.com, inc. (NYSE: CRM) today announced the initial public offering of 10,000,000 shares of its common stock at a price of $11.00 per share. Salesforce.com has also granted the underwriters an option to purchase an additional 1.5 million shares of common stock to cover over-allotments, if any. Salesforce.com's common stock will begin trading this morning on the New York Stock Exchange under the symbol 'CRM.'
Morgan Stanley is serving as the sole book runner for the offering, with Deutsche Bank Securities, UBS Investment Bank, Wachovia Securities and William Blair & Company acting as the co-managers of the offering. A copy of the final prospectus relating to the offering may be obtained from Morgan Stanley, Attn: Prospectus Department, 1585 Broadway, New York, NY 10036-6775, tel. (212) 761-6775, or firstname.lastname@example.org.
A registration statement relating to this offering was filed with and declared effective by the Securities and Exchange Commission. The offering is being made solely by means of a prospectus. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Any unreleased services or features referenced in this or other press releases or public statements are not currently available and may not be delivered on time or at all. Customers who purchase salesforce.com applications should make their purchase decisions based upon features that are currently available. Salesforce.com has headquarters in San Francisco, with offices in Europe and Asia, and trades on the New York Stock Exchange under the ticker symbol “CRM.” For more information please visit http://salesforce.com/au/, or call 1800 667 638 (Australia) or 0800 450 064 (New Zealand).